Do analysts prefer ZI or SVFCX?

ZoomInfo Technologies currently has a consensus target price of $6.00, suggesting a potential upside of 105.48%. Given ZoomInfo Technologies' stronger consensus rating and higher probable upside, analysts plainly believe ZoomInfo Technologies is more favorable than Smead Value C. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZoomInfo Technologies 2 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.80 Smead Value C 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, ZI or SVFCX?

ZoomInfo Technologies has higher revenue and earnings than Smead Value C. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ZoomInfo Technologies $1.21B 0.82 $107.30M $0.12 24.33 Smead Value C N/A N/A -$6.48M N/A N/A

Do analysts rate SVFCX or APXT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smead Value C 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Apex Technology Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, SVFCX or APXT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smead Value C N/A N/A -$6.48M N/A N/A Apex Technology Acquisition N/A N/A -$60.72M N/A N/A

Is SVFCX or APXT more profitable?

Smead Value C's return on equity of 0.00% beat Apex Technology Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Smead Value C N/A N/A -17.75% Apex Technology Acquisition N/A -750.42% -10.63%

Which has better earnings & valuation, MIXT or SVFCX?

MiX Telematics has higher revenue and earnings than Smead Value C. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiX Telematics $150.06M 2.36 $4.52M $0.25 58.20 Smead Value C N/A N/A -$6.48M N/A N/A

Do analysts prefer SVFCX or ULTI?

REX IncomeMax Option Strategy ETF has a consensus target price of $7.75, suggesting a potential upside of 0.00%. Given REX IncomeMax Option Strategy ETF's stronger consensus rating and higher possible upside, analysts clearly believe REX IncomeMax Option Strategy ETF is more favorable than Smead Value C. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smead Value C 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 REX IncomeMax Option Strategy ETF 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.66

Which has stronger earnings and valuation, SVFCX or ULTI?

REX IncomeMax Option Strategy ETF has higher revenue and earnings than Smead Value C. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smead Value C N/A N/A -$6.48M N/A N/A REX IncomeMax Option Strategy ETF $1.14B 0.02 $65.14M $2.07 3.74

Which has stronger earnings & valuation, MAQC or SVFCX?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Maquia Capital Acquisition N/A N/A -$960K -$0.03 N/A Smead Value C N/A N/A -$6.48M N/A N/A

Is MAQC or SVFCX more profitable?

Smead Value C's return on equity of 0.00% beat Maquia Capital Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Maquia Capital Acquisition N/A -10.66% 10.86% Smead Value C N/A N/A -17.75%

Smead Value C (SVFCX) Competitors

$94.63 -0.12 (-0.13%)

As of 07/23/2026

Compare

SVFCX vs. ZI, APXT, MIXT, ULTI, and MAQC

Should you buy Smead Value C stock or one of its competitors? MarketBeat compares Smead Value C with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Smead Value C include ZoomInfo Technologies (ZI), Apex Technology Acquisition (APXT), MiX Telematics (MIXT), REX IncomeMax Option Strategy ETF (ULTI), and Maquia Capital Acquisition (MAQC).

How does Smead Value C compare to ZoomInfo Technologies?

ZoomInfo Technologies (NASDAQ:ZI) and Smead Value C (NASDAQ:SVFCX) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

In the previous week, ZoomInfo Technologies had 1 more articles in the media than Smead Value C. MarketBeat recorded 1 mentions for ZoomInfo Technologies and 0 mentions for Smead Value C. ZoomInfo Technologies' average media sentiment score of 0.36 beat Smead Value C's score of 0.00 indicating that ZoomInfo Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
ZoomInfo Technologies	Neutral
Smead Value C	Neutral

ZoomInfo Technologies has a net margin of 0.74% compared to Smead Value C's net margin of 0.00%. ZoomInfo Technologies' return on equity of 12.05% beat Smead Value C's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ZoomInfo Technologies	0.74%	12.05%	3.46%
Smead Value C	N/A	N/A	-17.75%

ZoomInfo Technologies has higher revenue and earnings than Smead Value C.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ZoomInfo Technologies	$1.21B	0.82	$107.30M	$0.12	24.33
Smead Value C	N/A	N/A	-$6.48M	N/A	N/A

ZoomInfo Technologies currently has a consensus target price of $6.00, suggesting a potential upside of 105.48%. Given ZoomInfo Technologies' stronger consensus rating and higher probable upside, analysts plainly believe ZoomInfo Technologies is more favorable than Smead Value C.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ZoomInfo Technologies	2 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80
Smead Value C	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

ZoomInfo Technologies has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market.

95.5% of ZoomInfo Technologies shares are owned by institutional investors. Comparatively, 60.2% of Smead Value C shares are owned by institutional investors. 9.0% of ZoomInfo Technologies shares are owned by insiders. Comparatively, 10.3% of Smead Value C shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

ZoomInfo Technologies beats Smead Value C on 12 of the 13 factors compared between the two stocks.

How does Smead Value C compare to Apex Technology Acquisition?

Smead Value C (NASDAQ:SVFCX) and Apex Technology Acquisition (NASDAQ:APXT) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smead Value C	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Apex Technology Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Apex Technology Acquisition had 4 more articles in the media than Smead Value C. MarketBeat recorded 4 mentions for Apex Technology Acquisition and 0 mentions for Smead Value C. Apex Technology Acquisition's average media sentiment score of 1.20 beat Smead Value C's score of 0.00 indicating that Apex Technology Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
Smead Value C	Neutral
Apex Technology Acquisition	Positive

60.2% of Smead Value C shares are held by institutional investors. Comparatively, 6.0% of Apex Technology Acquisition shares are held by institutional investors. 10.3% of Smead Value C shares are held by insiders. Comparatively, 21.1% of Apex Technology Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smead Value C	N/A	N/A	-$6.48M	N/A	N/A
Apex Technology Acquisition	N/A	N/A	-$60.72M	N/A	N/A

Smead Value C's return on equity of 0.00% beat Apex Technology Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smead Value C	N/A	N/A	-17.75%
Apex Technology Acquisition	N/A	-750.42%	-10.63%

Smead Value C has a beta of 0.11, indicating that its share price is 89% less volatile than the broader market. Comparatively, Apex Technology Acquisition has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market.

Summary

Apex Technology Acquisition beats Smead Value C on 6 of the 9 factors compared between the two stocks.

How does Smead Value C compare to MiX Telematics?

MiX Telematics (NYSE:MIXT) and Smead Value C (NASDAQ:SVFCX) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

MiX Telematics has higher revenue and earnings than Smead Value C.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiX Telematics	$150.06M	2.36	$4.52M	$0.25	58.20
Smead Value C	N/A	N/A	-$6.48M	N/A	N/A

45.7% of MiX Telematics shares are held by institutional investors. Comparatively, 60.2% of Smead Value C shares are held by institutional investors. 12.4% of MiX Telematics shares are held by insiders. Comparatively, 10.3% of Smead Value C shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

MiX Telematics has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, suggesting that its stock price is 89% less volatile than the broader market.

In the previous week, MiX Telematics' average media sentiment score of 0.00 equaled Smead Value C'saverage media sentiment score.

Company	Overall Sentiment
MiX Telematics	Neutral
Smead Value C	Neutral

MiX Telematics has a net margin of 3.72% compared to Smead Value C's net margin of 0.00%. MiX Telematics' return on equity of 8.45% beat Smead Value C's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiX Telematics	3.72%	8.45%	5.11%
Smead Value C	N/A	N/A	-17.75%

Summary

MiX Telematics beats Smead Value C on 7 of the 8 factors compared between the two stocks.

How does Smead Value C compare to REX IncomeMax Option Strategy ETF?

Smead Value C (NASDAQ:SVFCX) and REX IncomeMax Option Strategy ETF (NASDAQ:ULTI) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

REX IncomeMax Option Strategy ETF has a net margin of 4.78% compared to Smead Value C's net margin of 0.00%. REX IncomeMax Option Strategy ETF's return on equity of 8.84% beat Smead Value C's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smead Value C	N/A	N/A	-17.75%
REX IncomeMax Option Strategy ETF	4.78%	8.84%	3.38%

REX IncomeMax Option Strategy ETF has a consensus target price of $7.75, suggesting a potential upside of 0.00%. Given REX IncomeMax Option Strategy ETF's stronger consensus rating and higher possible upside, analysts clearly believe REX IncomeMax Option Strategy ETF is more favorable than Smead Value C.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smead Value C	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
REX IncomeMax Option Strategy ETF	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.66

60.2% of Smead Value C shares are held by institutional investors. Comparatively, 91.2% of REX IncomeMax Option Strategy ETF shares are held by institutional investors. 10.3% of Smead Value C shares are held by insiders. Comparatively, 3.0% of REX IncomeMax Option Strategy ETF shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

REX IncomeMax Option Strategy ETF has higher revenue and earnings than Smead Value C.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smead Value C	N/A	N/A	-$6.48M	N/A	N/A
REX IncomeMax Option Strategy ETF	$1.14B	0.02	$65.14M	$2.07	3.74

In the previous week, REX IncomeMax Option Strategy ETF had 2 more articles in the media than Smead Value C. MarketBeat recorded 2 mentions for REX IncomeMax Option Strategy ETF and 0 mentions for Smead Value C. Smead Value C's average media sentiment score of 0.00 beat REX IncomeMax Option Strategy ETF's score of -0.07 indicating that Smead Value C is being referred to more favorably in the media.

Company	Overall Sentiment
Smead Value C	Neutral
REX IncomeMax Option Strategy ETF	Neutral

Smead Value C has a beta of 0.11, suggesting that its share price is 89% less volatile than the broader market. Comparatively, REX IncomeMax Option Strategy ETF has a beta of 3.36, suggesting that its share price is 236% more volatile than the broader market.

Summary

REX IncomeMax Option Strategy ETF beats Smead Value C on 11 of the 13 factors compared between the two stocks.

How does Smead Value C compare to Maquia Capital Acquisition?

Maquia Capital Acquisition (NASDAQ:MAQC) and Smead Value C (NASDAQ:SVFCX) are both prepackaged software industry companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maquia Capital Acquisition	N/A	N/A	-$960K	-$0.03	N/A
Smead Value C	N/A	N/A	-$6.48M	N/A	N/A

In the previous week, Maquia Capital Acquisition's average media sentiment score of 0.00 equaled Smead Value C'saverage media sentiment score.

Company	Overall Sentiment
Maquia Capital Acquisition	Neutral
Smead Value C	Neutral

Maquia Capital Acquisition has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, indicating that its share price is 89% less volatile than the broader market.

12.4% of Maquia Capital Acquisition shares are owned by institutional investors. Comparatively, 60.2% of Smead Value C shares are owned by institutional investors. 92.7% of Maquia Capital Acquisition shares are owned by company insiders. Comparatively, 10.3% of Smead Value C shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Smead Value C's return on equity of 0.00% beat Maquia Capital Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Maquia Capital Acquisition	N/A	-10.66%	10.86%
Smead Value C	N/A	N/A	-17.75%

Summary

Maquia Capital Acquisition and Smead Value C tied by winning 3 of the 6 factors compared between the two stocks.

Get Smead Value C News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SVFCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SVFCX vs. The Competition

Export

Metric	Smead Value C	Prepackaged Software Industry	Computer Sector	NASDAQ Exchange
Market Cap	$3.88B	$8.84B	$37.12B	$12.20B
Dividend Yield	N/A	0.89%	3.17%	9.41%
P/E Ratio	N/A	24.77	168.05	23.63
Price / Sales	N/A	4.90	596.19	111.98
Price / Cash	N/A	36.53	43.40	58.78
Price / Book	-63.09	11.16	9.07	6.01
Net Income	-$6.48M	$84.01M	$1.07B	$331.99M
7 Day Performance	N/A	0.09%	-1.81%	-0.63%
1 Month Performance	N/A	-4.36%	-3.68%	-3.04%
1 Year Performance	N/A	522.28%	133.84%	13.30%

Smead Value C Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SVFCX Smead Value C	N/A	$94.63 -0.1%	N/A	N/A	$3.88B	N/A	N/A	2
ZI ZoomInfo Technologies	2.3005 of 5 stars	$3.02 -1.9%	$6.00 +98.7%	-73.4%	$1.03B	$1.21B	100.70	3,540
APXT Apex Technology Acquisition	0.9365 of 5 stars	$10.08 +0.1%	N/A	-45.2%	$449.30M	N/A	N/A	N/A	News Coverage Positive News Short Interest Decrease
MIXT MiX Telematics	N/A	$14.55 flat	N/A	N/A	$353.75M	$150.06M	58.20	1,080
ULTI REX IncomeMax Option Strategy ETF	N/A	$9.17 -3.3%	N/A	N/A	$31.82M	$1.14B	4.43	5,162	Dividend Cut

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SVFCX) was last updated on 7/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Smead Value C (SVFCX) Competitors

SVFCX vs. ZI, APXT, MIXT, ULTI, and MAQC

How does Smead Value C compare to ZoomInfo Technologies?

Summary

How does Smead Value C compare to Apex Technology Acquisition?

Summary

How does Smead Value C compare to MiX Telematics?

Summary

How does Smead Value C compare to REX IncomeMax Option Strategy ETF?

Summary

How does Smead Value C compare to Maquia Capital Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SVFCX vs. The Competition

Smead Value C Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Smead Value C (SVFCX) Competitors

SVFCX vs. ZI, APXT, MIXT, ULTI, and MAQC

How does Smead Value C compare to ZoomInfo Technologies?

Does the media favor ZI or SVFCX?

Is ZI or SVFCX more profitable?

Which has stronger valuation and earnings, ZI or SVFCX?

Do analysts prefer ZI or SVFCX?

Which has more risk & volatility, ZI or SVFCX?

Do insiders & institutionals hold more shares of ZI or SVFCX?

Summary

How does Smead Value C compare to Apex Technology Acquisition?

Do analysts rate SVFCX or APXT?

Does the media favor SVFCX or APXT?

Do institutionals & insiders believe in SVFCX or APXT?

Which has better valuation and earnings, SVFCX or APXT?

Is SVFCX or APXT more profitable?

Which has more risk and volatility, SVFCX or APXT?

Summary

How does Smead Value C compare to MiX Telematics?

Which has better earnings & valuation, MIXT or SVFCX?

Do insiders and institutionals believe in MIXT or SVFCX?

Which has more volatility and risk, MIXT or SVFCX?

Does the media favor MIXT or SVFCX?

Is MIXT or SVFCX more profitable?

Summary

How does Smead Value C compare to REX IncomeMax Option Strategy ETF?

Is SVFCX or ULTI more profitable?

Do analysts prefer SVFCX or ULTI?

Do insiders & institutionals hold more shares of SVFCX or ULTI?

Which has stronger earnings and valuation, SVFCX or ULTI?

Does the media favor SVFCX or ULTI?

Which has more volatility & risk, SVFCX or ULTI?

Summary

How does Smead Value C compare to Maquia Capital Acquisition?

Which has stronger earnings & valuation, MAQC or SVFCX?

Does the media favor MAQC or SVFCX?

Which has more risk and volatility, MAQC or SVFCX?

Do institutionals & insiders have more ownership in MAQC or SVFCX?

Is MAQC or SVFCX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SVFCX vs. The Competition

Smead Value C Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools